Registered entities
Cumberland Pharmaceuticals Inc
Reg. No. 1087294United States
Innovation
32 patent families (21 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 3,215 times.
| Year | Filings |
|---|---|
| 2015 | 12 |
| 2016 | 9 |
| 2017 | 14 |
| 2018 | 12 |
| 2019 | 10 |
| 2020 | 11 |
| 2021 | 9 |
| 2022 | 3 |
| 2023 | 8 |
| 2024 | 4 |
| 2025 | 3 |
| 2026 | 1 |
Social engagement
Social engagement: 4.1K social following, 9 posts in the last 12 months — around the industry typical range.
Investor mix
2 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 50% |
| Other / undisclosed | 1 | 50% |
Recent activity
18 Jun 2026
Event
Medical insights webinar on CINV prevention with Sancuso® (Granisetron Transdermal System)